List of Excipients in API erlotinib
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing erlotinib
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
Physicians Total Care Inc | TARCEVA | erlotinib hydrochloride | 54868-5290 | CELLULOSE, MICROCRYSTALLINE | |
Physicians Total Care Inc | TARCEVA | erlotinib hydrochloride | 54868-5290 | FD&C YELLOW NO. 6 | |
Physicians Total Care Inc | TARCEVA | erlotinib hydrochloride | 54868-5290 | HYDROXYPROPYL CELLULOSE | |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing erlotinib
Company | Ingredient | NDC | Excipient |
---|---|---|---|
Teva Pharmaceuticals USA Inc | erlotinib | 0093-7662 | CELLULOSE, MICROCRYSTALLINE |
Teva Pharmaceuticals USA Inc | erlotinib | 0093-7662 | HYPROMELLOSE 2910 |
Teva Pharmaceuticals USA Inc | erlotinib | 0093-7662 | LACTOSE MONOHYDRATE |
>Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for erlotinib
Excipient focus: CELLULOSE, MICROCRYSTALLINE
erlotinib drug variants containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
Teva Pharmaceuticals USA Inc | erlotinib | 0093-7662 |
Teva Pharmaceuticals USA Inc | erlotinib | 0093-7663 |
Aurobindo Pharma Limited | erlotinib | 59651-530 |
>Company | >Ingredient | >NDC |
erlotinib drug variants not containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
Camber Pharmaceuticals Inc | erlotinib | 31722-263 |
Zydus Pharmaceuticals USA Inc | erlotinib | 68382-913 |
Cadila Healthcare Limited | erlotinib | 70771-1521 |
>Company | >Ingredient | >NDC |
Excipient focus: CROSPOVIDONE
erlotinib drug variants containing CROSPOVIDONE
Company | Ingredient | NDC |
---|---|---|
Zydus Pharmaceuticals USA Inc | erlotinib | 68382-913 |
Cadila Healthcare Limited | erlotinib | 70771-1521 |
>Company | >Ingredient | >NDC |
erlotinib drug variants not containing CROSPOVIDONE
Company | Ingredient | NDC |
---|---|---|
Teva Pharmaceuticals USA Inc | erlotinib | 0093-7662 |
Teva Pharmaceuticals USA Inc | erlotinib | 0093-7663 |
Camber Pharmaceuticals Inc | erlotinib | 31722-263 |
>Company | >Ingredient | >NDC |
Excipient focus: FD&C YELLOW NO. 6
erlotinib drug variants containing FD&C YELLOW NO. 6
Company | Ingredient | NDC |
---|---|---|
Physicians Total Care Inc | erlotinib hydrochloride | 54868-5290 |
>Company | >Ingredient | >NDC |
erlotinib drug variants not containing FD&C YELLOW NO. 6
Company | Ingredient | NDC |
---|---|---|
Teva Pharmaceuticals USA Inc | erlotinib | 0093-7662 |
Teva Pharmaceuticals USA Inc | erlotinib | 0093-7663 |
Camber Pharmaceuticals Inc | erlotinib | 31722-263 |
>Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CELLULOSE
erlotinib drug variants containing HYDROXYPROPYL CELLULOSE
Company | Ingredient | NDC |
---|---|---|
Camber Pharmaceuticals Inc | erlotinib | 31722-263 |
Aurobindo Pharma Limited | erlotinib | 59651-530 |
Areva Pharmaceuticals | erlotinib | 59923-727 |
>Company | >Ingredient | >NDC |
erlotinib drug variants not containing HYDROXYPROPYL CELLULOSE
Company | Ingredient | NDC |
---|---|---|
Teva Pharmaceuticals USA Inc | erlotinib | 0093-7662 |
Teva Pharmaceuticals USA Inc | erlotinib | 0093-7663 |
Sun Pharmaceutical Industries Inc | erlotinib | 63304-095 |
>Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
erlotinib drug variants containing HYPROMELLOSE
Company | Ingredient | NDC |
---|---|---|
Areva Pharmaceuticals | erlotinib | 59923-727 |
Alembic Pharmaceuticals Limited | erlotinib hydrochloride | 46708-565 |
Breckenridge Pharmaceutical Inc | erlotinib hydrochloride | 51991-890 |
>Company | >Ingredient | >NDC |
erlotinib drug variants not containing HYPROMELLOSE
Company | Ingredient | NDC |
---|---|---|
Teva Pharmaceuticals USA Inc | erlotinib | 0093-7662 |
Teva Pharmaceuticals USA Inc | erlotinib | 0093-7663 |
Camber Pharmaceuticals Inc | erlotinib | 31722-263 |
>Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE 2208
erlotinib drug variants containing HYPROMELLOSE 2208
Company | Ingredient | NDC |
---|---|---|
Sun Pharmaceutical Industries Inc | erlotinib | 63304-095 |
>Company | >Ingredient | >NDC |
erlotinib drug variants not containing HYPROMELLOSE 2208
Company | Ingredient | NDC |
---|---|---|
Teva Pharmaceuticals USA Inc | erlotinib | 0093-7662 |
Teva Pharmaceuticals USA Inc | erlotinib | 0093-7663 |
Camber Pharmaceuticals Inc | erlotinib | 31722-263 |
>Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE 2910
erlotinib drug variants containing HYPROMELLOSE 2910
Company | Ingredient | NDC |
---|---|---|
Teva Pharmaceuticals USA Inc | erlotinib | 0093-7662 |
Teva Pharmaceuticals USA Inc | erlotinib | 0093-7663 |
Camber Pharmaceuticals Inc | erlotinib | 31722-263 |
>Company | >Ingredient | >NDC |
erlotinib drug variants not containing HYPROMELLOSE 2910
Company | Ingredient | NDC |
---|---|---|
Areva Pharmaceuticals | erlotinib | 59923-727 |
Sun Pharmaceutical Industries Inc | erlotinib | 63304-095 |
Alembic Pharmaceuticals Limited | erlotinib hydrochloride | 46708-565 |
>Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSES
erlotinib drug variants containing HYPROMELLOSES
Company | Ingredient | NDC |
---|---|---|
Physicians Total Care Inc | erlotinib hydrochloride | 54868-5290 |
MSN LABORATORIES PRIVATE LIMITED | erlotinib hydrochloride | 69539-090 |
Novadoz Pharmaceuticals LLC | erlotinib hydrochloride | 72205-080 |
>Company | >Ingredient | >NDC |
erlotinib drug variants not containing HYPROMELLOSES
Company | Ingredient | NDC |
---|---|---|
Teva Pharmaceuticals USA Inc | erlotinib | 0093-7662 |
Teva Pharmaceuticals USA Inc | erlotinib | 0093-7663 |
Camber Pharmaceuticals Inc | erlotinib | 31722-263 |
>Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
erlotinib drug variants containing LACTOSE MONOHYDRATE
Company | Ingredient | NDC |
---|---|---|
Teva Pharmaceuticals USA Inc | erlotinib | 0093-7662 |
Teva Pharmaceuticals USA Inc | erlotinib | 0093-7663 |
Camber Pharmaceuticals Inc | erlotinib | 31722-263 |
>Company | >Ingredient | >NDC |
erlotinib drug variants not containing LACTOSE MONOHYDRATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
erlotinib drug variants containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
Teva Pharmaceuticals USA Inc | erlotinib | 0093-7662 |
Teva Pharmaceuticals USA Inc | erlotinib | 0093-7663 |
Camber Pharmaceuticals Inc | erlotinib | 31722-263 |
>Company | >Ingredient | >NDC |
erlotinib drug variants not containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
Breckenridge Pharmaceutical Inc | erlotinib hydrochloride | 51991-890 |
>Company | >Ingredient | >NDC |
Excipient focus: MICROCRYSTALLINE CELLULOSE 101
erlotinib drug variants containing MICROCRYSTALLINE CELLULOSE 101
Company | Ingredient | NDC |
---|---|---|
Zydus Pharmaceuticals USA Inc | erlotinib | 68382-913 |
Cadila Healthcare Limited | erlotinib | 70771-1521 |
>Company | >Ingredient | >NDC |
erlotinib drug variants not containing MICROCRYSTALLINE CELLULOSE 101
Company | Ingredient | NDC |
---|---|---|
Teva Pharmaceuticals USA Inc | erlotinib | 0093-7662 |
Teva Pharmaceuticals USA Inc | erlotinib | 0093-7663 |
Camber Pharmaceuticals Inc | erlotinib | 31722-263 |
>Company | >Ingredient | >NDC |
Excipient focus: MICROCRYSTALLINE CELLULOSE 102
erlotinib drug variants containing MICROCRYSTALLINE CELLULOSE 102
Company | Ingredient | NDC |
---|---|---|
Aurobindo Pharma Limited | erlotinib | 59651-530 |
Zydus Pharmaceuticals USA Inc | erlotinib | 68382-913 |
Cadila Healthcare Limited | erlotinib | 70771-1521 |
>Company | >Ingredient | >NDC |
erlotinib drug variants not containing MICROCRYSTALLINE CELLULOSE 102
Company | Ingredient | NDC |
---|---|---|
Teva Pharmaceuticals USA Inc | erlotinib | 0093-7662 |
Teva Pharmaceuticals USA Inc | erlotinib | 0093-7663 |
Camber Pharmaceuticals Inc | erlotinib | 31722-263 |
>Company | >Ingredient | >NDC |
Excipient focus: MICROCRYSTALLINE CELLULOSE 112
erlotinib drug variants containing MICROCRYSTALLINE CELLULOSE 112
Company | Ingredient | NDC |
---|---|---|
Camber Pharmaceuticals Inc | erlotinib | 31722-263 |
>Company | >Ingredient | >NDC |
erlotinib drug variants not containing MICROCRYSTALLINE CELLULOSE 112
Company | Ingredient | NDC |
---|---|---|
Teva Pharmaceuticals USA Inc | erlotinib | 0093-7662 |
Teva Pharmaceuticals USA Inc | erlotinib | 0093-7663 |
Aurobindo Pharma Limited | erlotinib | 59651-530 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYDEXTROSE
erlotinib drug variants containing POLYDEXTROSE
Company | Ingredient | NDC |
---|---|---|
Teva Pharmaceuticals USA Inc | erlotinib | 0093-7662 |
Teva Pharmaceuticals USA Inc | erlotinib | 0093-7663 |
>Company | >Ingredient | >NDC |
erlotinib drug variants not containing POLYDEXTROSE
Company | Ingredient | NDC |
---|---|---|
Camber Pharmaceuticals Inc | erlotinib | 31722-263 |
Aurobindo Pharma Limited | erlotinib | 59651-530 |
Areva Pharmaceuticals | erlotinib | 59923-727 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
erlotinib drug variants containing POLYETHYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
Areva Pharmaceuticals | erlotinib | 59923-727 |
Sun Pharmaceutical Industries Inc | erlotinib | 63304-095 |
Armas Pharmaceuticals Inc | erlotinib hydrochloride | 72485-217 |
>Company | >Ingredient | >NDC |
erlotinib drug variants not containing POLYETHYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
Teva Pharmaceuticals USA Inc | erlotinib | 0093-7662 |
Teva Pharmaceuticals USA Inc | erlotinib | 0093-7663 |
Camber Pharmaceuticals Inc | erlotinib | 31722-263 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 400
erlotinib drug variants containing POLYETHYLENE GLYCOL 400
Company | Ingredient | NDC |
---|---|---|
Camber Pharmaceuticals Inc | erlotinib | 31722-263 |
Mylan Pharmaceuticals Inc | erlotinib hydrochloride | 0378-7131 |
Mylan Institutional Inc | erlotinib hydrochloride | 42292-051 |
>Company | >Ingredient | >NDC |
erlotinib drug variants not containing POLYETHYLENE GLYCOL 400
Company | Ingredient | NDC |
---|---|---|
Teva Pharmaceuticals USA Inc | erlotinib | 0093-7662 |
Teva Pharmaceuticals USA Inc | erlotinib | 0093-7663 |
Aurobindo Pharma Limited | erlotinib | 59651-530 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 4000
erlotinib drug variants containing POLYETHYLENE GLYCOL 4000
Company | Ingredient | NDC |
---|---|---|
Zydus Pharmaceuticals USA Inc | erlotinib | 68382-913 |
Cadila Healthcare Limited | erlotinib | 70771-1521 |
Breckenridge Pharmaceutical Inc | erlotinib hydrochloride | 51991-890 |
>Company | >Ingredient | >NDC |
erlotinib drug variants not containing POLYETHYLENE GLYCOL 4000
Company | Ingredient | NDC |
---|---|---|
Teva Pharmaceuticals USA Inc | erlotinib | 0093-7662 |
Teva Pharmaceuticals USA Inc | erlotinib | 0093-7663 |
Camber Pharmaceuticals Inc | erlotinib | 31722-263 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 8000
erlotinib drug variants containing POLYETHYLENE GLYCOL 8000
Company | Ingredient | NDC |
---|---|---|
Teva Pharmaceuticals USA Inc | erlotinib | 0093-7662 |
Teva Pharmaceuticals USA Inc | erlotinib | 0093-7663 |
>Company | >Ingredient | >NDC |
erlotinib drug variants not containing POLYETHYLENE GLYCOL 8000
Company | Ingredient | NDC |
---|---|---|
Camber Pharmaceuticals Inc | erlotinib | 31722-263 |
Aurobindo Pharma Limited | erlotinib | 59651-530 |
Areva Pharmaceuticals | erlotinib | 59923-727 |
>Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
erlotinib drug variants containing PROPYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
MSN LABORATORIES PRIVATE LIMITED | erlotinib hydrochloride | 69539-090 |
Novadoz Pharmaceuticals LLC | erlotinib hydrochloride | 72205-080 |
>Company | >Ingredient | >NDC |
erlotinib drug variants not containing PROPYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
Teva Pharmaceuticals USA Inc | erlotinib | 0093-7662 |
Teva Pharmaceuticals USA Inc | erlotinib | 0093-7663 |
Camber Pharmaceuticals Inc | erlotinib | 31722-263 |
>Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
erlotinib drug variants containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Teva Pharmaceuticals USA Inc | erlotinib | 0093-7662 |
Teva Pharmaceuticals USA Inc | erlotinib | 0093-7663 |
Aurobindo Pharma Limited | erlotinib | 59651-530 |
>Company | >Ingredient | >NDC |
erlotinib drug variants not containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Camber Pharmaceuticals Inc | erlotinib | 31722-263 |
Areva Pharmaceuticals | erlotinib | 59923-727 |
Sun Pharmaceutical Industries Inc | erlotinib | 63304-095 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
erlotinib drug variants containing SODIUM LAURYL SULFATE
Company | Ingredient | NDC |
---|---|---|
Teva Pharmaceuticals USA Inc | erlotinib | 0093-7662 |
Teva Pharmaceuticals USA Inc | erlotinib | 0093-7663 |
Camber Pharmaceuticals Inc | erlotinib | 31722-263 |
>Company | >Ingredient | >NDC |
erlotinib drug variants not containing SODIUM LAURYL SULFATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
erlotinib drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Company | Ingredient | NDC |
---|---|---|
Teva Pharmaceuticals USA Inc | erlotinib | 0093-7662 |
Teva Pharmaceuticals USA Inc | erlotinib | 0093-7663 |
Camber Pharmaceuticals Inc | erlotinib | 31722-263 |
>Company | >Ingredient | >NDC |
erlotinib drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Company | Ingredient | NDC |
---|---|---|
Zydus Pharmaceuticals USA Inc | erlotinib | 68382-913 |
Cadila Healthcare Limited | erlotinib | 70771-1521 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM STEARYL FUMARATE
erlotinib drug variants containing SODIUM STEARYL FUMARATE
Company | Ingredient | NDC |
---|---|---|
Breckenridge Pharmaceutical Inc | erlotinib hydrochloride | 51991-890 |
>Company | >Ingredient | >NDC |
erlotinib drug variants not containing SODIUM STEARYL FUMARATE
Company | Ingredient | NDC |
---|---|---|
Teva Pharmaceuticals USA Inc | erlotinib | 0093-7662 |
Teva Pharmaceuticals USA Inc | erlotinib | 0093-7663 |
Camber Pharmaceuticals Inc | erlotinib | 31722-263 |
>Company | >Ingredient | >NDC |
Excipient focus: TALC
erlotinib drug variants containing TALC
Company | Ingredient | NDC |
---|---|---|
Sun Pharmaceutical Industries Inc | erlotinib | 63304-095 |
Zydus Pharmaceuticals USA Inc | erlotinib | 68382-913 |
Cadila Healthcare Limited | erlotinib | 70771-1521 |
>Company | >Ingredient | >NDC |
erlotinib drug variants not containing TALC
Company | Ingredient | NDC |
---|---|---|
Teva Pharmaceuticals USA Inc | erlotinib | 0093-7662 |
Teva Pharmaceuticals USA Inc | erlotinib | 0093-7663 |
Camber Pharmaceuticals Inc | erlotinib | 31722-263 |
>Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
erlotinib drug variants containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Teva Pharmaceuticals USA Inc | erlotinib | 0093-7662 |
Teva Pharmaceuticals USA Inc | erlotinib | 0093-7663 |
Camber Pharmaceuticals Inc | erlotinib | 31722-263 |
>Company | >Ingredient | >NDC |
erlotinib drug variants not containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: TRIACETIN
erlotinib drug variants containing TRIACETIN
Company | Ingredient | NDC |
---|---|---|
Teva Pharmaceuticals USA Inc | erlotinib | 0093-7662 |
Teva Pharmaceuticals USA Inc | erlotinib | 0093-7663 |
>Company | >Ingredient | >NDC |
erlotinib drug variants not containing TRIACETIN
Company | Ingredient | NDC |
---|---|---|
Camber Pharmaceuticals Inc | erlotinib | 31722-263 |
Aurobindo Pharma Limited | erlotinib | 59651-530 |
Areva Pharmaceuticals | erlotinib | 59923-727 |
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.